We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Lovenox Keeps Up Hot Start With Sales Nearing Half-Billion
Generic Lovenox Keeps Up Hot Start With Sales Nearing Half-Billion
February 2, 2011
The impact of Sandoz and Momenta Pharmaceuticals’ generic Lovenox continues to grow as the drug soared to $462 million in sales by the end of 2010 and moved Sandoz ahead of Mylan Pharmaceuticals as the second biggest generic-drug maker in the U.S.